0001062993-22-024501.txt : 20221227 0001062993-22-024501.hdr.sgml : 20221227 20221227191720 ACCESSION NUMBER: 0001062993-22-024501 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221222 FILED AS OF DATE: 20221227 DATE AS OF CHANGE: 20221227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heffernan Michael Thomas CENTRAL INDEX KEY: 0001448914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 221491432 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC. STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-12-22 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001448914 Heffernan Michael Thomas C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 1 0 0 0 Common Stock 2022-12-22 4 M 0 237 16.150 A 28260 D Common Stock 2022-12-22 4 S 0 237 23.0 D 28023 D Common Stock 2022-12-23 4 M 0 4989 16.150 A 33012 D Common Stock 2022-12-23 4 S 0 4989 23.0 D 28023 D Common Stock 2022-12-27 4 M 0 15995 16.150 A 44018 D Common Stock 2022-12-27 4 S 0 15995 23.63 D 28023 D Common Stock 2022-12-27 4 M 0 3820 16.150 A 31843 D Common Stock 2022-12-27 4 S 0 3820 24.16 D 28023 D Stock Option (Right to Purchase) 16.150 2022-12-22 4 M 0 237 0 D 2026-01-20 Common Stock 237 24804 D Stock Option (Right to Purchase) 16.150 2022-12-23 4 M 0 4989 0 D 2026-01-20 Common Stock 4989 19815 D Stock Option (Right to Purchase) 16.150 2022-12-27 4 M 0 15995 0 D 2026-01-20 Common Stock 15995 3820 D Stock Option (Right to Purchase) 16.150 2022-12-27 4 M 0 3820 0 D 2026-01-20 Common Stock 3820 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4). The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable. /s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan 2022-12-27